Concepedia
1
Publications
65
Citations
H-Index
2019
Active since
Affiliations
Qingdao University(Current)
Sarah L. Creamer is an author at Qingdao University.
Publications per year
2019–2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)
Tejal Patel, Joe Ensor, Sarah L. Creamer et al. · Breast Cancer Research · 2019 · 65 citations · Full text
Rows per page
1–1 of 1